Donafenib
New Drug Approvals
AUGUST 4, 2025
3] It is a deuterated derivative of sorafenib with improved pharmacokinetic properties. [4] 225 The presence of the deuterated methyl group in donafenib improves metabolic stability with prolonged half-life, lower systemic clearance, and higher systemic exposure.226 Lancet 2022, 400, 1345−1362. Llovet, J. 224) Vogel, A.;
Let's personalize your content